67. 多発性嚢胞腎
[臨床試験数:186,薬物数:196(DrugBank:47),標的遺伝子数:35,標的パスウェイ数:146

Searched query = "Polycystic kidney disease", "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00541853
(ClinicalTrials.gov)
December 20079/10/2007CCB Safety Study in Treatment of Hypertension of ADPKDComparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD PatientsKidney, Polycystic, Autosomal DominantDrug: Candesartan;Drug: Candesartan and Cilnidipine;Drug: Candesartan plus non-CCB agentsKyorin UniversityMinistry of Health, Labour and Welfare, JapanNot yet recruiting20 Years60 YearsBoth150Phase 4Japan